Profession

Industry experience needn’t always come post-academia – other options are available, as we learned in our chat with this Northern Irish PhD candidate

Our priorities paint a picture of who we are, and that’s as true in RNAi medicine development as it is elsewhere in life

Two drugs, two different destinies. Does their story prove that business practice makes the difference?

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

Five quotes to end the year in style – and thoughtfulness.

Sitting Down With… Tunde Bello, Vice President of Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb, New Jersey, USA.

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

Sitting Down With… Gen Li, CEO, Phesi

What did switching from client to constructor teach a seasoned biotech professional?

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world